Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

The funds will go towards scaling C2N Diagnostics’ laboratory services and advancing the company’s range of diagnostic tests.

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables people to live longer, healthier lives. Roche Diagnostics Corporation, the ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

Roche has announced the launch of the Roche Genentech Innovation Center Boston, which will serve as the company’s CVRM hub.

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there is still room for growth. See more.

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.